Dexcom Eyes US FDA Clearance For 15-Day CGM, But Insurance Coverage Remains Uncertain
Upgrade could boost Dexcom’s competitive positioning against Abbott’s Libre 3 Plus.
Tempering expectations on the immediate market impact for the upgraded continuous glucose monitor, Dexcom notes insurance coverage and pump integrations will take time to finalize.
